Intro

John Bazar opens the episode, introduces himself, and announces a new drug approval topic: mervituximab‑seravtansine for ovarian cancer.

Play episode from 00:00

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!